Recursion Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $9 From $10
Recursion Pharmaceuticals Inc:Leerink Partners將目標價從$10降至$9
Recursion Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $9 From $10
Recursion Pharmaceuticals Inc:Leerink Partners將目標價從$10降至$9
譯文內容由第三人軟體翻譯。